Eli Lilly's Investigational Drug Shows Potential in Diabetes Management
Eli Lilly's investigational drug, known as 'triple-G', has demonstrated significant effects on blood sugar and weight in a late-stage diabetes trial.
Editorial Staff Updated about 1 month ago